Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$3.17M Sell
67,242
-906
-1% -$48.1K 0.2% 98
2015
Q2
$3.7M Buy
68,148
+439
+0.6% +$24.6K 0.22% 92
2015
Q1
$3.71M Buy
67,709
+4,341
+7% +$246K 0.22% 92
2014
Q4
$3.43M Buy
63,368
+3,859
+6% +$215K 0.22% 87
2014
Q3
$3.37M Sell
59,509
-120
-0.2% -$6.74K 0.24% 78
2014
Q2
$3.29M Buy
59,629
+1,008
+2% +$55K 0.24% 80
2014
Q1
$3.17M Sell
58,621
-6,385
-10% -$331K 0.25% 73
2013
Q4
$3.1M Buy
65,006
+3,918
+6% +$179K 0.25% 73
2013
Q3
$2.77M Sell
61,088
-1,418
-2% -$64.7K 0.27% 66
2013
Q2
$2.77M Buy
+62,506
New +$2.79M 0.29% 63

Other funds holding MRK

OFI Advisors's MRK Position: Q3 2015 in Review

OFI Advisors reduced its Merck (MRK) stake by 1.3% in Q3 2015, selling an estimated $48.1K and leaving 67,242 shares worth $3.17M. The position accounts for 0.2% of the portfolio, ranked #98.

OFI Advisors first reported a position in MRK in Q2 2013 and has held it in 10 quarters since. The position peaked at $3.71M in Q1 2015. 1,672 funds tracked by Wall St. Rank hold MRK as of Q3 2015.

  • OFI Advisors held 67,242 shares of Merck worth $3.17M as of Q3 2015.
  • OFI Advisors sold 906 Merck shares in Q3 2015, an estimated $48.1K.
  • Merck made up 0.2% of OFI Advisors's portfolio in Q3 2015, its #98 holding.
  • OFI Advisors first reported a position in Merck in Q2 2013 and has held it in 10 quarters since.
  • OFI Advisors's Merck position peaked at $3.71M in Q1 2015.
  • 1,672 funds tracked by Wall St. Rank held Merck as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.